Methotrexate 17.5 mg/0.7 ml Injection in Pre-filled Syringe
Methotrexate 17.5 mg/0.7 ml Injection in Pre-filled Syringe — Immunosuppressants & Other Immunology Medicines, as a pre-filled syringe, available for private-label manufacture from 10,000 units, produced in Turkey. Below, the active substance of this Immunosuppressants & Other Immunology Medicines product appears under its International Nonproprietary Name, with the strength per unit that the specification gives.
Offered for the Gulf states
This page lists formulations we offer for the Gulf states only. The Products Library shows every formulation open in your market.
| Dosage form | Pre-filled syringe |
|---|---|
| Pack | 1 x 0.7 ml pre-filled syringe per box |
| Minimum order | 10,000 units |
| Manufactured in | Turkey |
| Market | Offered for the Gulf states |
| Documents | Certificate of Analysis, Certificate of Origin, Certificate of Conformity, Free Sale Certificate and MSDS — available on request. |
| Products Library | Open this formulation's card (F2167) |
Active ingredients
- Methotrexate 17.5 mg (25 mg/ml) per 0.7 ml pre-filled syringe
Solution for injection in a pre-filled syringe containing methotrexate 17.5 mg in 0.7 ml (25 mg/ml), a folic-acid antagonist. Prescription medicine for subcutaneous use under specialist supervision; one 0.7 ml pre-filled syringe per box.
This product is on offer for the Gulf states. Tell us the country and the quantity, and we answer with the offer and the documents we supply.
Country pages: Saudi Arabia · UAE · Kuwait · Qatar · Oman · Bahrain
Shipping and document legalisation for your country are calculated separately and stated in the offer.